PINK1 and cancer: In addition, PINK1 insufficiency sensitizes tumors to mitochondria-centric combination therapies, including Mdivi-1 and indomethacin, potentiating the translational opportunities of RNA modification-mediated regulation of PINK1 to cancer treatment [269].